Enhanced CD8+ T cell immune responses and protection elicited against Plasmodium berghei malaria by prime boost immunization regimens using a novel attenuated fowlpox virus.
D000276:Adjuvants, Immunologic / Q000008:administration & dosage* / Q000097:blood / Q000235:genetics; D000818:Animals; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology* / Q000469:parasitology / Q000821:virology; D005587:Fowlpox virus / Q000235:genetics / Q000276:immunology*; D005822:Genetic Vectors; D007115:Immunization Schedule; D007117:Immunization, Secondary / Q000379:methods; D008099:Liver / Q000166:cytology / Q000276:immunology; D008288:Malaria / Q000097:blood / Q000276:immunology* / Q000517:prevention & control; D017780:Malaria Vaccines / Q000008:administration & dosage* / Q000097:blood / Q000235:genetics / Q000276:immunology; D051379:Mice; D010962:Plasmodium berghei / Q000254:growth & development / Q000276:immunology*; D013154:Spleen / Q000166:cytology / Q000276:immunology; D034101:Sporozoites / Q000276:immunology; D014613:Vaccines, Attenuated / Q000008:administration & dosage / Q000097:blood / Q000235:genetics / Q000276:immunology; D017778:Vaccines, Combined / Q000008:administration & dosage / Q000276:immunology; D019444:Vaccines, DNA / Q000008:administration & dosage / Q000097:blood / Q000276:immunology
D000276:Adjuvants, Immunologic; D017780:Malaria Vaccines; D014613:Vaccines, Attenuated; D017778:Vaccines, Combined; D019444:Vaccines, DNA